表紙
市場調査レポート

世界の動物用抗感染薬市場:動物疾患、技術、動物、地域別 - 動向および予測

Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2015-2020

発行 Mordor Intelligence LLP 商品コード 319398
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
世界の動物用抗感染薬市場:動物疾患、技術、動物、地域別 - 動向および予測 Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2015-2020
出版日: 2016年01月01日 ページ情報: 英文
概要

世界の動物用抗感染薬市場は2014年に43億7,000万米ドルとなる見込みです。同市場は今後もCAGR8.5%で拡大し、2019年には69億2,000万米ドルに達するとみられています。動物の感染症の症例増加に対応するため、動物用抗感染薬市場は着実に成長を遂げています。

当レポートでは、世界の動物用抗感染薬市場の動向と将来予測、市場に参入する主要企業の競合環境、市場シェア、近年の動向とともにプロファイルをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品市場
  • 動物医療とヒトの医療

第3章 市場動向

  • 市場促進因子
    • ペット所有率の上昇
    • 栄養の改善
    • 食品安全に対する消費者の意識向上
    • 家畜生産の増大
    • 人畜共通感染症、食品媒介疾患
  • 市場阻害因子
    • 耕作地と水の不足
    • 耕地に関する競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 世界の動物用抗感染薬市場セグメンテーション

  • 世界の動物用抗感染薬市場:疾患別
  • 世界の動物用抗感染薬市場:種類別
    • コンパニオンアニマル
    • 家畜
  • 世界の動物用抗感染薬市場:地域別
    • 北米
    • 欧州
    • アジア太平洋地域

第5章 競合環境

  • 市場における主要参入企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、提携

第6章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Global market for veterinary anti-infectives is estimated to be worth $4570 million in 2015. Expected to grow at a healthy CAGR of 6.35%, the market is set to reach $6218 million by 2020. Global veterinary healthcare offers services and products in various segments such as Vaccine, Paraciticides , Anti-Invectives , Medicinal Feed additives , Other Pharmaceuticals out of which anti-invectives is growing at a steady pace to combat the increasing number of infectious diseases in animals.

It is the second best segment after vaccines and holds about 20% of the global animal healthcare market share.

The report highlights segment wise contribution of different anti-incentives segments by disease, species and geography to the global veterinary anti-infective market. By type of products like - Marbofloaxcine, Florfenicol, Freeze-dried ceftiofur, Beta-lactams, Oxytetracycline and Amminosidin; By species within companion farm animals and By Geographies like North America, South America, Asia-Pacific, Europe, Middleeast and Africa.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global animal anti-infectives market.

Drivers: Increase in pet ownership, Improved Nutrition, Increasing Zoonotic and Foodborne Diseases are the major driving forces which accelerates the global veterinary anti-invectives market

Constraints: Increased competition for cultivated land and Cost effective production happens to be major obstacles in the path of global veterinary anti-invectives market quest.

What the report offers:

  • 1. Market Definition for the specified topic along with identification of key drivers and restraints for the market.
  • 2. Market analysis for the Global veterinary anti-invectives Market, with region specific assessments and competition analysis on a global and regional scale.
  • 3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • 4. Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
  • 5. Identification and analysis of the Macro and Micro factors that affect the Global veterinary anti-invectives Market on both global and regional scale
  • 6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

  • Introduction
  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast
  • Research Assumptions
  • Executive Summary
  • Market Overview and Industry Trends
  • Current Market Senario
  • Veterinary Antiinfectives Overview
  • New Developments
  • Industry Value chain analysis
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat to new entrants
  • Threat to substitute products and services
  • Competitive Rivalry within the industry
  • Drivers, Restraints, Opportunities, and challenges Analysis
  • Market Drivers
  • Increase in pet ownership
  • Improved Nutrition
  • Intensifying consumer focus on food safety
  • Greater Livestock production
  • Increasing Zoonotic and Foodborne Diseases
  • Market Restraints
  • Scarcity of arable land and water
  • Increased competition for cultivated land
  • Cost effective productio
  • Key Challenges
  • Current Opportunities in the Market
  • Global Veterinary Antiinfectives Market, by Drug
  • Marbofloxacine
  • Florfenicol
  • Freeze-dried ceftiofur
  • Beta-lactams
  • Oxytetracycline
  • Amminosidin
  • Global Veterinary Diagnostics Market, by Animal
  • Companion Animals
  • Dogs
  • Cats
  • Horses
  • Farm animal
  • Cattle
  • Swine
  • Poultry
  • Fish
  • Sheep
  • Global Veterinary Diagnostics Market, by Geography
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain & Portugal
  • Scandinavia
  • BENELUX
  • Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Australia & Newzealand
  • South Korea
  • Rest of APAC
  • Middle-East and Africa (MEA)
  • GCC
  • Egypt
  • Morocco
  • Algeria
  • South Africa
  • Rest of MEA
  • South America
  • Brazil
  • Argentina
  • Rest of Latin America
  • Competitive Landscape
  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Parterships
  • Key Vendor Analysis
  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Ceva Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim
  • Analyst outlook for Investment opportunities
  • Future Outlook of the market
Back to Top